Business Overview: Earth Science Tech, Inc. (OTC: ETST)

---

Executive Summary

Earth Science Tech, Inc. is a Nevada-incorporated micro-cap company originally built around hemp-derived CBD (cannabidiol) and nutraceutical products, now transitioning into a small, diversified health and wellness holding company through acquisition. The company began in 2010 as a hemp-oil and CBD supplier, and after a period in court-appointed receivership, it has pursued a strategy of acquiring revenue-generating businesses — most notably RxCompoundStore.com, LLC (a compounding pharmacy) and Peaks Curative, LLC (a telemedicine-referral business for men's health treatments) — to rebuild and diversify its revenue base beyond its original CBD line.

Earth Science Tech is explicitly not a shell company: its most recent financial filings show real, growing revenue, a holding-company structure with operating subsidiaries, and a balance sheet with several million dollars in assets and over $1.5 million in cash — a small but genuine operating business rather than a dormant public shell.

---

1. Core Business Model & How They Work

Earth Science Tech operates two distinct, acquisition-linked lines of business under one small public holding company: its legacy CBD/nutraceutical products line, and a newer compounding-pharmacy/telemedicine business acquired to diversify and stabilize revenue.

[ Hemp Farming (Oregon/Kentucky) ] ➡️ [ CO₂ Supercritical Extraction ] ➡️ [ Lab-Tested CBD Oil/Nutraceuticals ] ➡️ [ Direct & Wholesale Sales ]

[ RxCompoundStore.com (Compounding Pharmacy) ] ➡️ [ Peaks Curative (Telemedicine Referral) ] ➡️ [ Compounded/Prescription Men's Health Products (e.g., tadalafil gummies) ]

Key Operational Drivers

1. CBD product line: Its flagship High Grade Full Spectrum Cannabinoids hemp oil is produced via supercritical CO₂ extraction from domestically grown hemp (family farms in Oregon and Kentucky), with lab testing for cannabinoid content, terpenoids, pesticides, residual solvents, mycotoxins, and microbes.
2. Acquisition-led diversification: Rather than relying solely on the volatile CBD category, the company has acquired a compounding pharmacy (RxCompoundStore.com) and a telemedicine-referral business (Peaks Curative) to add a recurring, prescription-linked revenue stream — including a proprietary compounded tadalafil gummy for erectile dysfunction marketed through telemedicine referrals.
3. Small, lean operating structure: The company has historically operated with a very small headcount (as few as three employees in its CBD-only era), relying heavily on acquired subsidiaries' existing teams and operations for its newer business lines.
4. Cross-selling intent: Management has stated an intent to cross-sell between its legacy CBD/nutraceutical customer base and the newly acquired pharmacy/telemedicine businesses.

---

2. Product Portfolio

---

3. Competitive Landscape

            REGULATORY COMPLEXITY
            Low (OTC supplement)           High (prescription/compounding)
Large  ┌─────────────────────────────┬─────────────────────────────┐
Scale  │ Major CBD/wellness brands    │ National compounding         │
       │ (Charlotte's Web, CV Sciences)│ pharmacy chains, telehealth   │
       │                              │ platforms (Hims & Hers, Ro)   │
       ├─────────────────────────────┼─────────────────────────────┤
Small  │ EARTH SCIENCE TECH (legacy   │ EARTH SCIENCE TECH (via       │
Scale  │ CBD line)                     │ RxCompoundStore/Peaks)        │
       └─────────────────────────────┴─────────────────────────────┘

Competitors by Business Line

• CBD/nutraceuticals: A highly fragmented, price-competitive hemp/CBD industry with numerous branded and private-label competitors, many with greater research resources and pricing flexibility than Earth Science Tech.
• Compounding pharmacy/telemedicine men's health: Larger telehealth-driven men's health platforms (e.g., Hims & Hers, Ro) and established compounding pharmacy chains compete for the same prescription-referral customer base, generally with far greater marketing budgets and brand recognition.

The company itself acknowledges the nutraceutical industry carries significant pricing pressure and that competitors may have superior resources, while positioning its full-spectrum CBD formulation as a point of product differentiation.

---

4. Strategic Strengths & Risks

Strengths

• Diversification beyond CBD: Acquiring a compounding pharmacy and telemedicine referral business reduces the company's former total dependence on the volatile, oversupplied CBD market.
• Vertically sourced, tested CBD product: Domestic hemp sourcing and in-process lab testing support product quality claims in a category where quality control is a genuine differentiator for discerning customers.
• Demonstrated real revenue and balance-sheet growth: Recent filings show increasing total assets and cash balances alongside revenue growth attributed to new accounts, evidence of actual operating traction rather than dormant shell status.

Risks

1. Micro-cap scale and resource constraints: With a historically tiny employee base and limited capital, Earth Science Tech cannot match the marketing or R&D spend of larger CBD or telehealth competitors.
2. Integration risk from acquisitions: Successfully integrating RxCompoundStore.com and Peaks Curative, and realizing the intended cross-selling benefits, carries execution risk typical of small-company roll-up strategies.
3. Legacy receivership history: The company's past court-appointed receivership reflects prior financial distress, and investors should weigh whether that history of distress could recur.
4. Regulatory exposure in both lines: CBD/hemp products face an evolving and uncertain regulatory landscape, while compounded pharmaceuticals and telemedicine-based prescribing face their own distinct regulatory scrutiny (e.g., state pharmacy board and telehealth prescribing rules).
5. OTC market liquidity and visibility: As an OTC-traded micro-cap, the stock likely has limited institutional coverage, analyst visibility, and trading liquidity compared to exchange-listed peers.

---

5. Financial Overview

---

6. Summary Conclusion

Earth Science Tech has evolved from a single-product CBD oil supplier emerging from receivership into a small, diversified health and wellness holding company spanning hemp-derived nutraceuticals and a newer compounding-pharmacy/telemedicine men's-health business. Its real (if modest) revenue growth, growing balance sheet, and acquisition-led diversification strategy distinguish it from a dormant shell, but its micro-cap scale, acquisition-integration risk, and history of financial distress mean its biggest forward risk is simply execution: whether management can successfully fold RxCompoundStore.com and Peaks Curative into a cohesive, cross-selling business before competitive pressure in either the CBD or telehealth-pharmacy markets erodes the gains it has made so far.